Back to mobile site

Wedbush Maintains an 'Outperform' on XOMA, Ltd. (XOMA); Recent Financing Extends Cash Runway Into Q3:11 and Through Major Clinical Value Drivers in Q1:11

December 30, 2010 8:46 AM EST Send to a Friend
Wedbush maintains an 'Outperform' on XOMA, Ltd. (NASDAQ: XOMA), PT $12.

Wedbush analyst says, "The company expects to end the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login